How severe is CVE-2023-37397?

CVE-2023-37397 has a CVSS 3.x base score of 3.6, rated low severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2023-37397 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-37397?

CVE-2023-37397 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-37397?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2023-37397 have an EU (EUVD) identifier?

Yes. CVE-2023-37397 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41298.

When was CVE-2023-37397 published?

CVE-2023-37397 was published on 2024-04-19 and last updated on 2026-06-17.

CVE-2023-37397

CVE-2023-37397 is a low-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 3.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-326.

Key facts

Severity: Low (CVSS 3.x base score 3.6)
EPSS exploit prediction: 0% (1st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2023-41298
Weakness: CWE-326
Affected product: Ibm Aspera Faspex
Published: 2024-04-19
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to obtain or modify sensitive information due to improper encryption of certain data. IBM X-Force ID: 259672.

Frequently asked questions

What is CVE-2023-37397?: IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to obtain or modify sensitive information due to improper encryption of certain data. IBM X-Force ID: 259672.
How severe is CVE-2023-37397?: CVE-2023-37397 has a CVSS 3.x base score of 3.6, rated low severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2023-37397 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-37397?: CVE-2023-37397 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-37397?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-37397 have an EU (EUVD) identifier?: Yes. CVE-2023-37397 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41298.
When was CVE-2023-37397 published?: CVE-2023-37397 was published on 2024-04-19 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-326 (Inadequate Encryption Strength) vulnerabilities

CVE-2026-44523 — Critical (CVSS 10.0): Note Mark is an open-source note-taking application. Prior to 0.19.4, no minimum length or entropy is enforced on the…
CVE-2020-6966 — Critical (CVSS 10.0): In ApexPro Telemetry Server Versions 4.2 and prior, CARESCAPE Telemetry Server v4.2 & prior, Clinical Information…
CVE-2014-9199 — Critical (CVSS 10.0): The Clorius Controls Java web client before 01.00.0009g allows remote attackers to discover credentials by sniffing the…
CVE-2018-25272 — Critical (CVSS 9.8): ELBA5 5.8.0 contains a remote code execution vulnerability that allows attackers to obtain database credentials and…
CVE-2025-12478 — Critical (CVSS 9.8): Non-Compliant TLS Configuration.This issue affects BLU-IC2: through 1.19.5; BLU-IC4: through 1.19.5 .
CVE-2022-24116 — Critical (CVSS 9.8): Certain General Electric Renewable Energy products have inadequate encryption strength. This affects iNET and iNET II…

Browse all CWE-326 (Inadequate Encryption Strength) vulnerabilities →